• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  Rifapentine
Trade Name:  Priftin
Date Designated:  06/09/1995
Orphan Designation:  Treatment of pulmonary tuberculosis.
Orphan Designation Status:  Designated/Approved
Marketing Approval Date:  06/22/1998 
Approved Labeled Indication:  
Exclusivity End Date:    06/22/2005 
Exclusivity Protected Indication* :  
Hoechst Marion Roussel
P.O. Box 9627
Mail Station: H3-M2516
Kansas City, Missouri 64134
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.